MPN defined here as subjects with aCML, CNL, or MPN not otherwise specified. Blank indicates wild-type or benign polymorphism; NA, not applicable; NT, not tested; fs*, frame shift mutation; *, truncation mutation; †, likely as a compound mutation; ‡ M160delinsYEM. Courtesy of Richard D. Press and Erin Wiedmeier.

Other genes tested in this next generation sequencing panel but without pathogenic mutations: ABL1, BCOR, CBLB, CREBBP, DNMT3A, ETV6, FBXW7, FLT3, GATA1, GATA2, HRAS, IDH1, IDH2, IKZF1, IL7R, JAK1, JAK3, KIT, KRAS, MLL-PTD, MPL, NOTCH1, NPM1, NRAS, PAX5, PTPN11, RUNX1, SF3B1, STAT3, SUZ12, TET2, TP53, WT1, and ZRSR2.